The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Valsol plus 160 mg/25 mg film-coated tablets

160mg/25 milligram(s) Film-coated tablet

Laboratorios LICONSA, S.A.PA1239/007/003

Main Information

Trade NameValsol plus 160 mg/25 mg film-coated tablets
Active SubstancesValsartan
Hydrochlorothiazide
Strength160mg/25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/007/003

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA03 valsartan and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued01/10/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0040-078-003
Interchangeable List DocumentPDF of Interchangeable List
« Back